NOVAVAX INC Quarterly Goodwill in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Novavax Inc quarterly Goodwill history and growth rate from Q4 2010 to Q3 2024.
  • Novavax Inc Goodwill for the quarter ending September 30, 2024 was $127M, a 2.41% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $127M +$2.99M +2.41% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $123M -$4.99M -3.89% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $123M -$6.65M -5.12% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $127M +$1.12M +0.89% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $124M +$6.25M +5.31% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $128M +$4.9M +3.97% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $130M -$929K -0.71% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $126M -$5.15M -3.92% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $118M -$14.5M -11% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $123M -$10.8M -8.06% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $131M -$123K -0.09% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $131M -$3.9M -2.88% Dec 31, 2021 10-K 2024-02-28
Q3 2021 $132M +$5.06M +3.98% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $134M +$15.4M +13% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $131M +$80.9M +162% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $135M +$84.2M +165% Dec 31, 2020 10-K 2023-02-28
Q3 2020 $127M +$76.6M +152% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $119M +$67.6M +132% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $50M -$1.26M -2.45% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $51.2M -$813K -1.56% Dec 31, 2019 10-K 2022-03-01
Q3 2019 $50.3M -$1.77M -3.39% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $51.3M -$703K -1.35% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $51.2M -$2.04M -3.83% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $52M -$1.6M -2.98% Dec 31, 2018 10-K 2021-03-01
Q3 2018 $52.1M -$1.67M -3.12% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $52M -$1.01M -1.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $53.3M +$1.35M +2.59% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $53.6M +$1.89M +3.66% Dec 31, 2017 10-K 2020-03-11
Q3 2017 $53.7M +$1.05M +2% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $53M +$50K +0.09% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $51.9M -$1.83M -3.39% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $51.7M -$1.39M -2.62% Dec 31, 2016 10-K 2019-03-18
Q3 2016 $52.7M -$368K -0.69% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $52.9M -$366K -0.69% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $53.8M +$1.1M +2.09% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $53.1M -$1.55M -2.83% Dec 31, 2015 10-K 2018-03-14
Q3 2015 $53.1M -$3.11M -5.54% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $53.3M -$4.6M -7.94% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $52.7M -$5.96M -10.2% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $54.6M -$4.1M -6.98% Dec 31, 2014 10-K 2017-02-27
Q3 2014 $56.2M -$2.59M -4.4% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $57.9M +$24.8M +74.7% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $58.6M +$25.5M +76.9% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $58.7M +$25.6M +77.1% Dec 31, 2013 10-K 2016-02-29
Q3 2013 $58.8M +$25.6M +77.3% Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $33.1M $0 0% Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $33.1M $0 0% Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $33.1M $0 0% Dec 31, 2012 10-K 2015-02-27
Q3 2012 $33.1M $0 0% Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $33.1M $0 0% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $33.1M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $33.1M $0 0% Dec 31, 2011 10-K 2014-03-12
Q3 2011 $33.1M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $33.1M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 $33.1M Dec 31, 2010 10-K 2012-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.